Sunitinib: a newly approved small-molecule inhibitor of angiogenesis.
about
Multimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular responseDeveloping and applying a gene functional association network for anti-angiogenic kinase inhibitor activity assessment in an angiogenesis co-culture model.Molecular regulation of tumor angiogenesis and perfusion via redox signaling.Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway.Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2VEGF/VEGFR signalling as a target for inhibiting angiogenesis.Metabolism and bioactivation of famitinib, a novel inhibitor of receptor tyrosine kinase, in cancer patients.In vivo antitumor and antimetastatic activity of sunitinib in preclinical neuroblastoma mouse model.Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple MyelomaInhibition of tumor angiogenesis and tumor growth by the DSL domain of human Delta-like 1 targeted to vascular endothelial cells.Nanoparticles as new tools for inhibition of cancer angiogenesis.Coexpression of receptor-tyrosine-kinases in gastric adenocarcinoma--a rationale for a molecular targeting strategy?Fatal liver failure in a patient on acetaminophen treated with sunitinib malate and levothyroxine.De novo design of N-(pyridin-4-ylmethyl)aniline derivatives as KDR inhibitors: 3D-QSAR, molecular fragment replacement, protein-ligand interaction fingerprint, and ADMET prediction.Usnic acid inhibits breast tumor angiogenesis and growth by suppressing VEGFR2-mediated AKT and ERK1/2 signaling pathways.Circulating perivascular progenitors: a target of PDGFR inhibition.
P2860
Q28384680-D422CF98-5DE5-4557-9AC2-36C7F5F885F8Q33339727-C4ECA264-6C3D-42AD-B6DF-570A89F6C6B6Q33572306-6F6443FC-0E64-452F-AB0F-0F08A88D5CB8Q34132787-D11C9D74-D0C4-4E81-9834-3B7D3D7C7153Q35940368-A4B5C866-1635-4A10-98FE-7E9A199FE2DDQ36677407-B74CE95C-DCB0-497E-957A-95FA1A051B03Q36709236-2B8E399D-F05B-406C-A63B-A6B8DCB68FF5Q37165842-A156967E-A30F-42B3-B5F2-387E8C25B15DQ38974261-09759E8A-EEE4-4CDE-90FB-4FEBD4EF5E99Q39132553-EE53F6A0-EAAC-449D-A064-5CA553E3174AQ39329359-27145165-5AC9-448C-BC27-96C5A3E01A62Q42846225-49C8785C-84DC-4629-887E-B1B199FFBE67Q46066638-C7B4D8FB-49E7-4F23-ADC2-9E186F205BF1Q54475869-ABECEE15-E8B0-4CB8-9948-AABABDBBD52CQ54506451-38644414-A6B4-4F23-B091-115861D3F057Q54628938-4E96E113-5EFD-4908-8442-B903A4F07B7A
P2860
Sunitinib: a newly approved small-molecule inhibitor of angiogenesis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Sunitinib: a newly approved small-molecule inhibitor of angiogenesis.
@ast
Sunitinib: a newly approved small-molecule inhibitor of angiogenesis.
@en
type
label
Sunitinib: a newly approved small-molecule inhibitor of angiogenesis.
@ast
Sunitinib: a newly approved small-molecule inhibitor of angiogenesis.
@en
prefLabel
Sunitinib: a newly approved small-molecule inhibitor of angiogenesis.
@ast
Sunitinib: a newly approved small-molecule inhibitor of angiogenesis.
@en
P1433
P1476
Sunitinib: a newly approved small-molecule inhibitor of angiogenesis.
@en
P2093
Elwyn Cabebe
Heather Wakelee
P304
P356
10.1358/DOT.2006.42.6.985633
P577
2006-06-01T00:00:00Z